BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.

Charles University Prague Faculty of Medicine in Hradec Kralové Simkova 870 Hradec Kralove 500 38 Czech Republic

Clinic of Urology University Hospital Hradec Kralové Sokolska 581 Hradec Králové 50005 Czech Republic

Institute of Clinical Microbiology University Hospital Hradec Kralové Sokolska 581 Hradec Králové 50005 Czech Republic

Zobrazit více v PubMed

Frimondt-Møller N. Chapter 73 – Fosfomycin, in Kucers’ The Use of Antibiotics, 6th Edition. Lead Editor M. Lindsay Grayson. USA: CRC Press. 2010

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi: 10.1111/j.1469-0691.2011.03570.x. PubMed DOI

Kaase M, Szabados F, Anders A, Gatermann SG. Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol. 2014;52(6):1893–1897. doi: 10.1128/JCM.03484-13. PubMed DOI PMC

Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents. 2009;34(2):111–120. doi: 10.1016/j.ijantimicag.2009.03.009. PubMed DOI

Mihailescu R, Furustrand Tafin U, Corvec S, Oliva A, Betrisey B, Borens O, Trampuz A. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother. 2014;58(5):2547–2553. doi: 10.1128/AAC.02420-12. PubMed DOI PMC

Neuner EA, Sekeres J, Hall GS, van Duin D. Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrob Agents Chemother. 2012;56(11):5744–5748. doi: 10.1128/AAC.00402-12. PubMed DOI PMC

The European Association of Urology. Guidelines on Urological Infection, version 2015. http://uroweb.org/guideline/urological-infections/?type=archive

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 5.0, 2015. http://www.eucast.org/ast_of_bacteria/previous_versions_of_documents/.

The Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; Twenty – Third Informational Supplement. Pennsylvania 19087, USA, 2013.

Hrabák J, Bergerová T, Zemličková H, Urbášková P. Detection of extended-spectrum ß-lactamases, AmpC ß-lactamases, metallo-ß-lactamases and Klebsiella pneumoniae carbapenemases in Gram-negative rods. Zprávy EMI. 2009;18(3):100–106.

Koningstein M, van der Bij AK, de Kraker MEA, Monen JC, Muilwijk J, de Greeff SC, Geerlings SE, van Hall MA ISIS-AR Study Group Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands. PLoS ONE. 2014;9(1):e86634. doi: 10.1371/journal.pone.0086634. PubMed DOI PMC

Cassir N, Rolain JM, Brouqui P. A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Front Microbiol. 2014;5:551. doi: 10.3389/fmicb.2014.00551. PubMed DOI PMC

Gupta V, Rani H, Singla N, Kaisha N, Chander J. Determination of Extended-Spectrum- β-Lactamases and AmpC production in uropathogenic isolates of Escherichia coli and susceptibility to Fosfomycin. J Lab Physicians. 2013;5(2):90–93. doi: 10.4103/0974-2727.119849. PubMed DOI PMC

Miranda EJ, Oliveira GS, Roque FL, Santos SR, Olmos RD, Lotufo PA. Susceptibility to antibiotics in urinary tract infections in a secondary care setting from 2005-2006 and 2010-2011, in São Paulo, Brazil: data from 11,943 urine cultures. Rev Inst Med Trop Sao Paulo. 2014;56(4):313–324. doi: 10.1590/S0036-46652014000400009. PubMed DOI PMC

Qiao L-D, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, Yang WM, Zhao XK, Gao XF, Chen M, Tian Y. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open. 2013;3:e004152. doi: 10.1136/bmjopen-2013-004152. PubMed DOI PMC

Sorlozano A, Jimenez-Pacheco A, de Dios Luna Del Castillo J, Sampedro A, Martinez-Brocal A, Miranda-Casas C, Navarro-Marí JM, Gutiérrez-Fernández J. Evolution of the resistance to antibiotics of bacteria involved in urinary tract infection: a 7-year surveillance study. Am J Infect Control. 2014;42(10):1033–1038. doi: 10.1016/j.ajic.2014.06.013. PubMed DOI

Perdigão-Neto LV, Oliveira MS, Rizek CF, Carrilho CM, Costa SF, Levin AS. Susceptibility of multiresistant gram-negative bacteria to fosfomycin and performance of different susceptibility testing methods. Antimicrob Agents Chemother. 2014;58(3):1763–1767. doi: 10.1128/AAC.02048-13. PubMed DOI PMC

Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect. 2011;44(5):364–368. doi: 10.1016/j.jmii.2010.08.012. PubMed DOI

Chislett RJ, White G, Hills T, Turner DP. Fosfomycin susceptibility among extended-spectrum beta-lactamase producing Escherichia coli in Nottingham, UK. J Antimicrob Chemother. 2010;65:1076–1077. doi: 10.1093/jac/dkq051. PubMed DOI

Schmiemann G, Gágyor I, Hummers-Pradier E, Bleidorn Resistance profiles of urinary tract infections in general practice - an observational study. BMC Urol. 2012;12:33. doi: 10.1186/1471-2490-12-33. PubMed DOI PMC

Rodríguez-Avial C, Rodríguez-Avial I, Hernández E, Picazo JJ. Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011) Rev Esp Quimioter. 2013;26(1):43–46. PubMed

Current antibiotic resistance patterns of rare uropathogens: survey from Central European Urology Department 2011-2019

Current Antibiotic Resistance Trends of Uropathogens in Central Europe: Survey from a Tertiary Hospital Urology Department 2011-2019

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study